Search

everythinglearnresearchcommunity

for

Search:↓

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Hirsutism worsens quality of life and mental health, and treatment with both medical help and therapy is most effective.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

The document emphasizes standardized, comprehensive training for dermatology and venereology specialists across Europe.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Stem cell therapy improves healing and reduces pain in cutaneous radiation syndrome.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Genetic differences affect how people respond to COVID-19.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Certain drugs can change hair color, either lightening or darkening it.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.